Company Filing History:
Years Active: 2006-2014
Title: The Innovations of Bin Ye
Introduction
Bin Ye is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to ovarian cancer. With a total of 3 patents to his name, his work focuses on innovative methods for early detection and monitoring of this critical disease.
Latest Patents
One of Bin Ye's latest patents is titled "Urinary CA125 peptides as biomarkers of ovarian cancer." This invention is directed towards diagnostic methods that utilize the detection of peptides derived from the degradation of CA125. The primary aim is to analyze urine samples collected from women to assess their risk of ovarian cancer, monitor treatment efficacy, and determine if cancer has recurred or advanced. Another significant patent is "Eosinophil-derived neurotoxin as a marker for ovarian cancer." This invention outlines methods for identifying women at increased risk of ovarian cancer based on elevated levels of eosinophil-derived neurotoxin (EDN) in biological samples.
Career Highlights
Bin Ye is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the early detection and treatment of ovarian cancer, improving outcomes for many women.
Collaborations
Throughout his career, Bin Ye has collaborated with notable colleagues, including Daniel Cramer and Samuel C Mok. These partnerships have fostered a collaborative environment that enhances the research and development of innovative diagnostic methods.
Conclusion
Bin Ye's contributions to the field of ovarian cancer diagnostics exemplify the importance of innovation in medical research. His patents reflect a commitment to improving women's health through advanced diagnostic techniques.